Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week.
Journal Of Acquired Immune Deficiency Syndromes (1999)
Schürmann, Dirk D; Jackson Rudd, Deanne D; Schaeffer, Andrea A; De Lepeleire, Inge I; Friedman, Evan J EJ; Robberechts, Martine M; Zhang, Saijuan S; Liu, Yang Y; Kandala, Bhargava B; Keicher, Christian C; Däumer, Martin M; Hofmann, Jörg J; Grobler, Jay A JA; Stoch, S Aubrey SA; Iwamoto, Marian M; Ankrom, Wendy W
Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.
Journal Of Acquired Immune Deficiency Syndromes (1999)
Schürmann, Dirk D; Rudd, Deanne Jackson DJ; Schaeffer, Andrea A; De Lepeleire, Inge I; Friedman, Evan J EJ; Robberechts, Martine M; Zhang, Saijuan S; Liu, Yang Y; Kandala, Bhargava B; Keicher, Christian C; Däumer, Martin M; Hofmann, Jörg J; Grobler, Jay A JA; Stoch, S Aubrey SA; Iwamoto, Marian M; Ankrom, Wendy W
Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.
Viruses
Porter, Danielle P DP; Daeumer, Martin M; Thielen, Alexander A; Chang, Silvia S; Martin, Ross R; Cohen, Cal C; Miller, Michael D MD; White, Kirsten L KL